Peer Reviewed
editorialoffice@confseries.net
+44 7897-071619
Follow Us:
Home
Instructions for Authors
Author Guidelines
Author Submission Policies
Publication Ethics and Policies
Editorial Panel
Editor-in-Chief
Editorial Board
Editorial Form
Submit Manuscript
Aims and Scope
Articles in Process
Archive
Contact
Journal of Pharma and Drug Innovation
Now Accepting Manuscripts
Annual (One issue per year)
Open Access
Single-Blind Peer Review
Manuscript Guidelines
Journals
Membership
Editorial & Review Timeline
3 - 4 Days
Initial Quality Review
20 Days
Peer Evaluation Summary
30 - 45 Days
Complete Editorial Processing Time
Volume 1, Issue 1 (2026)
Research Article
|
J. Pharma Drug Innov. 2026 June 26; 1(1): 22 - 34
Design, Synthesis, and Antibacterial Evaluation of Novel Scaffold Pyrimidine Derivatives: A Structure-Activity Relationship Study
Santanu Kumar Hotta
1*
,
Krishna Chandra Panda
2
,
Asish Kumar Mohanty
1
,
Kanhu Charan Bisoyi
1
,
Pratibha Pradeep Pal
1
and
Smruti Suman Mahapatra
1
Abstract
html
PDF
Perspective
|
J. Pharma Drug Innov. 2026 June 08; 1(1): 20 - 21
Nanopharmaceuticals: Advances, Applications, and Future Perspectives in Drug Delivery and Therapeutics
Cherry Adams
*
html
PDF
Review Article
|
J. Pharma Drug Innov. 2026 June 04; 1(1): 9 - 19
Gut Dysbiosis: A Key Player in Metabolic health Management
Krishna Chandra Panda
*
,
B.V.V Ravi Kumar
*
,
Jammula Sruti
*
,
Digambar Bisoi
*
and
Laxmidhar Sahoo
*
Abstract
html
PDF
Editorial
|
J. Pharma Drug Innov. 2026 April 07; 1(1): 6 - 8
Nanostructured Systems and Therapeutic Innovation: Challenges and Opportunities
Eleonora Russo
*
html
PDF
Review Article
|
J. Pharma Drug Innov. 2026 March 04; 1(1): 1 - 5
Artificial Intelligence in Drug Discovery: Trends, Challenges, and Future Perspectives
Aura Rusu
*
Abstract
html
PDF
Abstract
html
PDF